
Advanced Registration is now closed. You may register onsite at the SCSHP meeting registration desk located outside the Compass Ballroom at the North Charleston Marriott.
Registration Hours:
- Thursday, March 2 (7:00 AM - 6:00 PM)
- Friday, March 3 (7:30 AM - 3:30 PM)
4770 Goer Dr
North Charleston, SC 29406
Date: Mar 2, 2023 08:00 AM - Mar 3, 2023 03:30 PM
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
![]() |
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
- Check in upon arrival at the meeting
- Complete the online program evaluations
- Provide the correct month and day of birth and NABP e-Profile ID. Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education. To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.
- Summarize trends in hospital pharmacy practice, including the adoption of best practices and Practice Advancement Initiative (PAI) 2030 recommendations
- Explain results of the ASHP National Survey of Pharmacy Practice related to current challenges in health-system pharmacy practice
Speaker(s)/Author(s)
Paul W. Bush, PharmD, MBA, BCPS, FASHP
|
Activity Number
0062-9999-23-035-L04-P/TCE Hours
- Review the current CDC immunization schedules
- Identify recently updated ACIP recommendations for routine vaccinations in adult patients
- Discuss hepatitis B, influenza, pneumococcal, zoster, and COVID-19 vaccine schedules
- Summarize recommendations regarding MMR, meningococcal, and varicella vaccines
Speaker(s)/Author(s)
Kayla Antosz, PharmD
|
|
Reagan Barfield, PharmD, BCPS
|
Activity Number
0062-9999-23-043-L06-P/TCE Hours
- Select an appropriate strategy for perioperative anticoagulant management
- Discuss recent shifts in the evidence-based management of anticoagulation after ischemic stroke
- Examine potential new anticoagulant therapies under investigation
- Review appropriate treatments for perioperative anticoagulant management
- Identify factors that impact the timing of anticoagulation after ischemic stroke
- Recognize potential new anticoagulant therapies under investigation
Speaker(s)/Author(s)
Joe Kramer, PharmD, BCPS, BCCCP
|
Activity Number
0062-9999-23-044-L01-P/TCE Hours
- Compare and contrast the classifications and stages of heart failure (HF)
- Apply therapeutic principles from the new 2022 AHA/ACC/HFSA heart failure guidelines, including initiation and titration of guideline-directed medical therapies (GDMT), to patient-specific scenarios
- Describe when and how additional medical therapies (beyond the core four GDMT) should be integrated into the management of HF with reduced ejection fraction (HFrEF)
- Explain practical strategies to mitigate potential barriers to GDMT initiation
- Compare and contrast the classifications and stages of heart failure (HF)
- Identify treatment options from the new 2022 AHA/ACC/HFSA HF guidelines for the different HF classifications
- Recognize potential barriers to guideline-directed medical therapy (GDMT) initiation
Speaker(s)/Author(s)
Jason S. Haney, PharmD, BCPS, BCCCP
|
Activity Number
0062-9999-23-045-L01-P/TCE Hours
- Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
- Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
- Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions
Activity Number
0062-9999-23-046-L01-P/TCE Hours
- Evaluate the differences in lipid-lowering pharmacotherapy practices in Type 2 diabetes mellitus between rural and urban fairly qualified health center practice sites
- Evaluate the use of sodium zirconium cyclosilicate in critically ill patients
- Discuss COVID-19 vaccine enthusiasm and hesitancy amongst rural South Carolina populations
Activity Number
0062-9999-23-047-L01-P/TCE Hours
- Describe the types of services most commonly offered by health system based Centralized Pharmacy Services
- Describe the advantages of placing a centralized pharmacy within a multipurpose shared services facility versus operating a standalone pharmacy
- List two potential criticisms of operating a centralized pharmacy
Speaker(s)/Author(s)
Ken Jozefczyk, MS, RPh, FASHP, BCSCP
|
Activity Number
0062-9999-23-048-L04-PCE Hours
- Describe the landscape of hyperlipidemia within South Carolina and its subsequent implications
- Identify the key differences between non-statin therapies and their place in therapy
- Formulate patient-specific questions to gain the most important information for building an appropriate treatment plan
- Apply the updated hyperlipidemia guidelines and treatment options to patient cases
- Describe the landscape of hyperlipidemia within South Carolina
- Identify the key differences between non-statin therapies
- Apply the updated hyperlipidemia guidelines and treatment options to patient cases
Speaker(s)/Author(s)
Carrington Royals, PharmD
|
Activity Number
0062-9999-23-049-L01-P/TCE Hours
- Evaluate treatment options for weight management, specifically weight loss
- Identify the risks and benefits associated with anti-obesity medications
- Summarize potential barriers to anti-obesity medications
Speaker(s)/Author(s)
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
|
Activity Number
0062-9999-23-050-L01-P/TCE Hours
- Recognize the prevalence of medication diversion in the hospital setting
- Describe components of a medication diversion prevention and detection program
- Identify methods to detect medication diversion
- Discuss reporting requirements following suspected or confirmed medication diversion
Speaker(s)/Author(s)
Sarah Bush Mattmuller, PharmD, BCPS
|
Activity Number
0062-9999-23-051-L04-P/TCE Hours
- Identify and explain the newest legislation impacting pharmacy practice
- Review older regulations and requirements that may cause board citations or confusion in your pharmacy
Speaker(s)/Author(s)
Nancy A. Taylor, RPh, CDCES
|
Activity Number
0062-9999-23-052-L03- P/TCE Hours
- Review the etiology and current guideline recommendations for the management of urinary tract infections
- Discuss the primary literature surrounding duration of therapy for urinary tract infections in the male population
- Discuss the primary literature surrounding the safety and efficacy of urinary tract infection prophylaxis in high-risk populations
Speaker(s)/Author(s)
Michael K. Shaw, PharmD
|
Activity Number
0062-9999-23-053-L01-P/TCE Hours
- Identify antifungal agents in the pipeline and their potential role in therapy
- Discuss potential treatment strategies for persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
- Utilize temperature excursion resources to optimize temperature excursion management
- Review the role of terlipressin in the management of hepatorenal syndrome
Speaker(s)/Author(s)
Abbie L. Blunier, PharmD
|
|
Cassidy H. Kemp, PharmD
|
|
Jake Crocker, PharmD
|
|
Justin White, PharmD
|